The downgrade by Barclays from Overweight to Equal-Weight, along with a significant reduction in the price target, suggests a less optimistic outlook on Ulta Beauty's stock performance in the short term. This could lead to negative investor sentiment and potentially a decrease in stock price as market participants adjust their expectations based on this new analyst rating.